SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ahn J, Cohen S. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2008; 14: 16031608.
  • 2
    Gottesdiener KM. Transplanted infections: donor-to-host. Ann Intern Med 1989; 110: 10011016.
  • 3
    Wilck M, Fishman JA. The challenges of infection in transplantation: donor-derived infections. Curr Opin Organ Transplant 2005; 10: 301306.
  • 4
    Centers for Disease Control and Prevention. West Nile virus infection in organ donor and transplant recipients—Georgia and Florida, 2002. MMWR 2002; Public Health Dispatch September 6, 2002.
  • 5
    Centers for Disease Control and Prevention. Detection of West Nile virus in blood donations—United States, 2003. MMWR Surveill Summ 2003; 52: 769772.
  • 6
    Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, et al. , Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 21962203.
  • 7
    Centers for Disease Control and Prevention. West Nile virus infection in organ transplant recipients—New York and Pennsylvania, August–September, 2005. MMWR Surveill Summ 2005; 54 (dispatch): 13.
  • 8
    Health Resources and Services Administration. A special announcement from HRSA regarding West Nile Virus. Available at: http://www.unos.org/news. Accessed June 2008.
  • 9
    Srinivasan A, Burton EC, Kuehnert MJ, Rupprecht C, Sutker WL, Ksiazek TG, et al. , Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352: 11031111.
  • 10
    Rabies in patients who received organ transplants in Germany. CDR Wkly (Online) 2005;15:News.
  • 11
    Bronnert J, Wilde H, Tepsumethanon V, Lumlertdacha B, Hemachudha T. Review article: organ transplantation and rabies transmission. J Travel Med 2007; 14: 177180.
  • 12
    De Serres G, Dallaire F, Cote M, Skowronski DM. Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact. Clin Infect Dis 2008; 46: 13291337.
  • 13
    Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, et al. , Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006; 354: 22352249.
  • 14
    Centers for Disease Control and Prevention. Lymphocytic choriomeningitis virus infection in organ transplant recipients—Massachusetts, Rhode Island, 2005. MMWR Surveill Summ 2005; 54: 537539.
  • 15
    Palacios G, Druce J, Du L, Tran T, Birch C, Briese T, et al. A new arenavirus in a cluster of fatal transplant-associated disease. N Engl J Med 2008; 358: 991998.
  • 16
    Centers for Disease Control and Prevention. Interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with pet rodents. interim guidance. MMWR Surveill Summ 2005; 54: 747749.
  • 17
    Centers for Disease Control and Prevention. Update: interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with pet rodents. MMWR Surveill Summ 2005; 54: 799801.
  • 18
    Gonzalez-Perez MP, Munoz-Juarez L, Cardenas F, Imirizaldu JJZ, Carraceja JC, Garcia-Saiz A. Human T-cell leukemia virus type I infection in various recipients of transplant from the same donor. Transplantation 2003; 75: 10061011.
  • 19
    Centers for Disease Control and Prevention. Recommendations for counseling persons infected with human T-lymphotrophic virus, type I and II. MMWR Recomm Rep 1993; 42(RR-9): 113.
  • 20
    Shames BD, D'Alessandro AM, Sollinger HW. Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy? Am J Transplant 2002; 2: 658663.
  • 21
    OPTN: Organ Procurement and Transplantation Network. Available at: http://www.optn.org/latestData/rptData.asp. Accessed May 2008.
  • 22
    Attia M, Silva MA, Mirza DF. Review: the marginal liver donor—an update. Transpl Int 2008; 21: 713724.
  • 23
    Centers for Disease Control and Prevention. Guidelines for preventing transmission of human Immunodeficiency Virus through transplantation of human tissue and organs. MMWR Recomm Rep 1994; 43( RR-8): 117.
  • 24
    United Network for Organ Sharing. Summary of actions taken at the OPTN/UNOS Executive Committee Meeting—December 18, 2007. Available at: http://www.unos.org. Accessed August 2008.
  • 25
    Molmenti EP, Smith DM, Molmenti H, Fasola CG, Aguanno JJ, Savino AC, et al. Unusually high incidence of positive HTLVI/II results among young female organ donors in the peripartum period. Dig Dis Sci 2002; 47: 23832385.
  • 26
    Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid amplification testing. N Engl J Med 2004; 351: 760768.
  • 27
    Aswad S, Khan NS, Comanor L, Chinchilla C, Corado L, Mone T, et al. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors. J Viral Hepat 2005; 12: 627634.
  • 28
    U.S. Food and Drug Administration. Guidance for Industry. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps)). August 2007. Available at: http://www.fda.gov/cber/gdlns/tissdonor.pdf. Accessed June 2008.